Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma
出版年份 2017 全文链接
标题
Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 293, Issue 7, Pages 2452-2465
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2017-12-27
DOI
10.1074/jbc.ra117.000667
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Proteomic characterization of human multiple myeloma bone marrow extracellular matrix
- (2017) S V Glavey et al. LEUKEMIA
- Therapy for Relapsed Multiple Myeloma
- (2017) David Dingli et al. MAYO CLINIC PROCEEDINGS
- The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma
- (2017) Yuji Mishima et al. Cell Reports
- Genetic interrogation of circulating multiple myeloma cells at single-cell resolution
- (2016) J. G. Lohr et al. Science Translational Medicine
- Predicting the response of multiple myeloma to the proteasome inhibitor Bortezomib by evaluation of the unfolded protein response
- (2016) N Nikesitch et al. Blood Cancer Journal
- De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas
- (2016) Sihem Mebarki et al. Oncotarget
- Microenvironment drug resistance in multiple myeloma: emerging new players
- (2016) Lucia Di Marzo et al. Oncotarget
- Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
- (2015) J Laubach et al. LEUKEMIA
- Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer
- (2015) Suniti Misra et al. Frontiers in Immunology
- A critical role for the NFkB pathway in multiple myeloma
- (2015) Oncotarget
- Overcoming bortezomib resistance in multiple myeloma
- (2014) Megan Y. Murray et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back
- (2014) Giada Bianchi et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF- B Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells
- (2014) J. C. Godbersen et al. CLINICAL CANCER RESEARCH
- Matricryptins and matrikines: biologically active fragments of the extracellular matrix
- (2014) Sylvie Ricard-Blum et al. EXPERIMENTAL DERMATOLOGY
- Covalent Modification of the NF-κB Essential Modulator (NEMO) by a Chemical Compound Can Regulate Its Ubiquitin Binding Propertiesin Vitro
- (2014) Christopher Hooper et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Global cellular response to chemotherapy-induced apoptosis
- (2013) Arun P Wiita et al. eLife
- Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells
- (2012) Jaehyup Kim et al. BRITISH JOURNAL OF HAEMATOLOGY
- NF- B, the first quarter-century: remarkable progress and outstanding questions
- (2012) M. S. Hayden et al. GENES & DEVELOPMENT
- Ubiquitination in signaling to and activation of IKK
- (2012) Zhijian J. Chen IMMUNOLOGICAL REVIEWS
- Initial genome sequencing and analysis of multiple myeloma
- (2011) Michael A. Chapman et al. NATURE
- Inflammation meets cancer, with NF-κB as the matchmaker
- (2011) Yinon Ben-Neriah et al. NATURE IMMUNOLOGY
- The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
- (2011) P. Walter et al. SCIENCE
- MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF- B-dependent lymphoma
- (2010) M. A. Milhollen et al. BLOOD
- Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1and p57Kip2CDK inhibitors
- (2010) Zhimin Lu et al. CELL CYCLE
- Non-canonical NF-κB signaling pathway
- (2010) Shao-Cong Sun CELL RESEARCH
- Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
- (2010) Stephanie Markovina et al. Molecular Cancer
- Distinct Genetic Alterations in Colorectal Cancer
- (2010) Hassan Ashktorab et al. PLoS One
- Oncogenic Activation of NF- B
- (2010) L. M. Staudt Cold Spring Harbor Perspectives in Biology
- Bortezomib induces canonical nuclear factor- B activation in multiple myeloma cells
- (2009) T. Hideshima et al. BLOOD
- Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells
- (2009) Hongjuan Dong et al. LEUKEMIA & LYMPHOMA
- Multiple myeloma
- (2008) R. A. Kyle et al. BLOOD
- Molecular basis of bortezomib resistance: proteasome subunit 5 (PSMB5) gene mutation and overexpression of PSMB5 protein
- (2008) R. Oerlemans et al. BLOOD
- Bone marrow microenvironment and the identification of new targets for myeloma therapy
- (2008) K Podar et al. LEUKEMIA
- Bortezomib-Resistant Nuclear Factor- B Activity in Multiple Myeloma Cells
- (2008) S. Markovina et al. MOLECULAR CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started